Patents by Inventor Josh Bauer

Josh Bauer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Markers of Triple-Negative Breast Cancer and Uses Thereof
    Publication number: 20240158865
    Abstract: In one aspect provided herein are methods of determining a triple negative breast cancer (TNBC) subtype in an individual in need thereof comprising determining expression of one or more genes in one or more TNBC cells of the individual; and comparing the expression of the one or more genes in the TNBC cells with the expression of the one or more genes in a control. In another aspect, the methods are directed to determining a treatment protocol for the TNBC patient based on the TNBC subtype. In another aspect, the methods are directed to predicting whether an individual will benefit from a treatment for a particular TNBC subtype. In yet another aspect, the invention is directed to a method of determining whether an agent can be used to treat a TNBC subtype.
    Type: Application
    Filed: October 17, 2023
    Publication date: May 16, 2024
    Inventors: Jennifer A. Pietenpol, Brian Lehmann, Josh Bauer, Xi Chen
  • Markers of triple-negative breast cancer and uses thereof
    Patent number: 11788147
    Abstract: In one aspect provided herein are methods of determining a triple negative breast cancer (TNBC) subtype in an individual in need thereof comprising determining expression of one or more genes in one or more TNBC cells of the individual; and comparing the expression of the one or more genes in the TNBC cells with the expression of the one or more genes in a control. In another aspect, the methods are directed to determining a treatment protocol for the TNBC patient based on the TNBC subtype. In another aspect, the methods are directed to predicting whether an individual will benefit from a treatment for a particular TNBC subtype. In yet another aspect, the invention is directed to a method of determining whether an agent can be used to treat a TNBC subtype.
    Type: Grant
    Filed: January 17, 2020
    Date of Patent: October 17, 2023
    Assignee: Vanderbilt University
    Inventors: Jennifer A. Pietenpol, Brian Lehmann, Josh Bauer, Xi Chen
  • Markers of Triple-Negative Breast Cancer and Uses Thereof
    Publication number: 20200224282
    Abstract: In one aspect provided herein are methods of determining a triple negative breast cancer (TNBC) subtype in an individual in need thereof comprising determining expression of one or more genes in one or more TNBC cells of the individual; and comparing the expression of the one or more genes in the TNBC cells with the expression of the one or more genes in a control. In another aspect, the methods are directed to determining a treatment protocol for the TNBC patient based on the TNBC subtype. In another aspect, the methods are directed to predicting whether an individual will benefit from a treatment for a particular TNBC subtype. In yet another aspect, the invention is directed to a method of determining whether an agent can be used to treat a TNBC subtype.
    Type: Application
    Filed: January 17, 2020
    Publication date: July 16, 2020
    Inventors: Jennifer A. Pietenpol, Brian Lehmann, Josh Bauer, Xi Chen
  • Markers of Triple-Negative Breast Cancer And Uses Thereof
    Publication number: 20140303133
    Abstract: In one aspect provided herein are methods of determining a triple negative breast cancer (TNBC) subtype in an individual in need thereof comprising determining expression of one or more genes in one or more TNBC cells of the individual; and comparing the expression of the one or more genes in the TNBC cells with the expression of the one or more genes in a control. In another aspect, the methods are directed to methods of determining a treatment protocol for the TNBC patient based on the TNBC subtype. In another aspect, the methods are directed to predicting whether an individual will benefit from a treatment for a particular TNBC subtype. In yet another aspect, the invention is directed to a method of determining whether an agent can be used to treat a TNBC subtype.
    Type: Application
    Filed: November 17, 2012
    Publication date: October 9, 2014
    Inventors: Jennifer A. Pietenpol, Brian Lehmann, Josh Bauer, Xi Chen